The antitumor activity of an anti-CD54 a
β
Kimberly J. Brooks; Elaine J. Coleman; Ellen S. Vitetta
π
Article
π
2008
π
John Wiley and Sons
π
French
β 293 KB
## Abstract We have previously described the development and testing of a monoclonal antiβhuman CD54 antibody (UV3) in SCID mice xenografted with human multiple myeloma, lymphoma, and melanoma cell lines. In all 3 cases, UV3 was highly effective at slowing the growth of tumors and/or prolonging sur